Микробиологическое снижение содержания афлатоксина М1 в молочных продуктах: систематический обзор эффективности, механистических ограничений и аналитической достоверности
AFM1 Removal Efficacy, Proposed Mechanisms, and Key Methodological Limitations Across 34 Included Studies
GI: gastrointestinal; CFU: colony-forming units; NPs: nanoparticles; MS/MS: tandem mass spectrometry
Study | Microorganism(s) | Dairy Matrix | Peak Removal (%) | Proposed Mechanism | Key Methodological Limitation |
Barukčić et al. | LAB starter cultures | Fermented milk | 13–31 | Adsorption | Low efficacy; toxin dissociation observed during refrigerated storage |
Rezasoltani et al. | S. boulardii, L. casei | Reconstituted milk | 75–88 | Binding | Efficacy inversely correlated with initial AFM1 concentration |
Kuharić et al. | Native LAB | Raw milk | >50 | Binding/physical | Required centrifugation and filtration; industrially cost-prohibitive |
Sanaldi & Coban | Probiotics | Various milk types | 40–70 | Adsorption | High variability with milk fat content; mechanism undetermined |
Salem-Bekhit et al. | L. rhamnosus, S. cerevisiae | Milk | >90 | Adsorption | Efficacy contingent on Box–Behnken process optimization |
Jebelli Javan et al. | Cottage cheese LAB isolates | Milk | 35–65 | Binding | Strain-specific; binding destabilized under high-acidity conditions |
Sarlak et al. | Probiotics | Doogh | 50–65 | Adsorption | Significant alterations to sensory and fermentation profiles |
Martínez et al. | Mixed bacteria and yeasts | Milk | 80–100 | Degradation (claimed) | One of four degradation-claiming studies; metabolites not structurally identified by MS/MS |
Anvar et al. | S. boulardii + LAB | Milk | 60–80 | Biophysical | Multi-step biophysical process; scalability undemonstrated |
Abdelmotilib et al. | Probiotic cocktails | Milk | >90 | Adsorption | Non-specific binding of milk macronutrients documented |
Gonçalves et al. | Non-viable LAB | Frescal cheese | 40–60 | Adsorption | Efficacy dependent on high biomass concentrations (>10⁹ CFU/mL) |
Panwar et al. | Indian Lactobacilli | Simulated GI model | 30–55 | Binding | Significant toxin desorption during simulated gastric phase |
Ismail et al. | High-concentration microbes | Milk | 45–95 | Binding | Requires excessive microbial loads (>10⁹ CFU/mL) for peak efficacy |
Adácsi et al. | Cell fractions | Milk | 30–50 | Surface binding | Fractionated cells showed lower efficacy versus intact cells |
Güner et al. | Inactivated LAB | Milk | 60–85 | Adsorption | Heat-inactivation compromised binding site structural integrity |
Riad et al. | Synbiotic + ZnO nanoparticles | Milk | >95 | Complexation | Potential cytotoxicity of ZnO nanoparticle residues not assessed |
Hamad et al. | Nanoencapsulation cocktail | Milk | 85–98 | Adsorption | High technical complexity; residual toxin risk unquantified |
Hashemi & Amiri | L. reuteri | Sarshir | 70–90 | Adsorption | Confirmed high desorption rates under acidic and ionic conditions |
Nahle et al. | LAB biofilms | Milk | 60–80 | Bio-sequestration | Industrial biofilm maintenance not feasible at scale |
Kamyar & Movassaghghazani | Kefir starter culture | Milk | 40–55 | Adsorption | Fermentation time constraints limit practical applicability |
Adriansyah et al. | Kefir microbiota | Milk | 30–60 | Binding | High inter-grain variability; standardization unaddressed |
Jiménez-Pérez et al. | Kefir-derived polysaccharides | Milk | 40–55 | Adsorption | Low binding capacity compared to living biomass |
Møller et al. | Multiple LAB strains | In vitro (milk) | 20–80 | Multi-toxin binding | Non-specific; co-sequestration of fat-soluble vitamins documented |
Rabie et al. | Probiotics | Dairy products | 45–70 | Binding | Post-storage toxin recovery confirmed in multiple product formats |
Fakhrabadipour et al. | B. bifidum | Skim milk | 55–80 | Adsorption | Efficacy markedly reduced in full-fat matrix |
Almutairi et al. | L. lactis + inulin | Milk | 65–85 | Adsorption | Prebiotic–toxin interactions complicate safety interpretation |
Assaf et al. | L. rhamnosus biofilm | Milk | 80–100 | Adsorption | High removal rate, but biofilm sloughing risk identified |
Gonçalves et al. | Mixed methods | Cheese | 40–60 | Binding | Incomplete removal in complex solid matrix |
Faghihi et al. | Probiotics vs. natamycin | Milk | 50–75 | Adsorption | Microbial binding less stable than chemical natamycin benchmark |
Fagbemi | L. brevis | Raw milk | 35–55 | Binding | Low efficacy against raw milk contaminants; mechanism uncharacterized |
Shahrestani et al. | Probiotics | Milk | 50–70 | Adsorption | pH fluctuations triggered measurable toxin release |
Yüksel & Albayrak | L. plantarum NRRL B4496 | Milk | 40–65 | Adsorption | Reversibility confirmed by wash-step desorption experiments |
Sevim et al. | Novel biological agents | Milk | 70–95 | Adsorption | AFM1 bioaccessibility remained elevated following treatment |
Chaudhary & Patel | W. confusa, L. plantarum | Milk/aqueous | 60–90 | Adsorption | High efficacy but mechanism confirmed as purely surface-based |
